Insider Transactions in Q1 2024 at Cerevel Therapeutics Holdings, Inc. (CERE)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2024
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-76.18%
|
$2,050,000
$41.01 P/Share
|
|
Mar 04
2024
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+43.24%
|
$150,000
$3.5 P/Share
|
|
Feb 29
2024
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-76.18%
|
$2,050,000
$41.16 P/Share
|
|
Feb 29
2024
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+43.24%
|
$150,000
$3.5 P/Share
|
|
Feb 20
2024
|
Perceptive Advisors LLC Director |
SELL
Bona fide gift
|
Indirect |
170,317
-100.0%
|
-
|
|
Feb 07
2024
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
2,506
-13.81%
|
$102,746
$41.54 P/Share
|
|
Feb 07
2024
|
John Renger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,161
-25.33%
|
$88,601
$41.54 P/Share
|
|
Feb 06
2024
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
15,440
+45.97%
|
-
|
|
Feb 06
2024
|
John Renger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,020
+37.05%
|
-
|
|
Jan 02
2024
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-94.87%
|
$2,100,000
$42.24 P/Share
|
|
Jan 02
2024
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+48.68%
|
$150,000
$3.5 P/Share
|